Vanta Bioscience Limited (BOM:540729)

Market Cap	123.72M -15.2%
Revenue (ttm)	18.16M -7.5%
Net Income	1.08M
EPS	0.15
Shares Out	6.31M
PE Ratio	130.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Open	19.60
Previous Close	n/a
Day's Range	19.60 - 19.60
52-Week Range	14.71 - 29.00
Beta	0.99
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Vanta Bioscience

Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India. The company offers a range of services in method development, validation, impurity profiling, impurity isolation, characterization, certification and evaluation, mammalian and genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development. It also provides testing services for agrochemicals and chemicals, such as physico-chemical testing; sub-acute, sub-chronic, an...

• Industry: Commercial Physical and Biological Research
• Founded: 2016
• Employees: 36
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540729

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 8, 2026

Data Sources Report a data error